Mr. Quigley most recently led McKinsey & Company’s Private Capital practice and previously led various Life Sciences practices at the ...

Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...

Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” ...

After pioneering haptic gloves for virtual reality, Tokyo-based startup Diver-X is taking aim at one of the most familiar computer tools: the ...

BioMarin will host a conference call and webcast to discuss third quarter 2025 financial results today, Monday, October 27, 2025, at 4:30 p.m. ET. This event can be accessed through this link or on ...

Research by Assistant Professor Jacob S. Suissa at the University of Tennessee, Knoxville, is revealing complexity in how ...